The thesis
News-sentiment is a long-only tactical strategy with a simple mandate: buy on positive recent news sentiment, exit on negative. It runs across a 24-name large-cap universe spanning tech (AAPL, MSFT, GOOGL, NVDA), financials (JPM, BAC, V, MA), healthcare (JNJ, UNH, PFE, ABBV), staples (PG, KO, WMT, COST), and a handful of industrials and energy names (CAT, HON, XOM, CVX). The logic is intuitive and easy to reason about — a point in its favour when so many strategies are black boxes.
Recent activity
The strategy is flagged live. Its most recent executions landed on 23 September: a buy of 4 NVDA at $225.34 and a sell of 35 BAC at $55.96, unwinding a position opened in June. Earlier summer trades included GOOGL, UNH, MSFT and AAPL buys.
Since then, things have gone quiet. The scheduled runs from 2–9 October executed nothing — cash sat unchanged at $2,036.71 while the account total drifted between roughly $10,233 and $10,416. Notably, the 8 and 9 October runs each logged one rejected order, hinting that the strategy wanted to act but couldn't — likely a cash, sizing, or threshold constraint worth investigating.
Backtest and validation
Over a 451-day backtest the numbers are, bluntly, flat: +0.19% total return, ~0.1% CAGR, Sharpe 0.74, and a remarkably small 0.05% max drawdown. Turnover was 36.5%, fees just $2, across only 2 trades (win rate 0).
That small trade count is the whole story. Walk-forward validation ran 4 folds and did not pass: only 1 fold was positive, and folds 1–3 took zero trades. Every ounce of performance comes from fold 4 (Dec 2025–May 2026), which posted +0.19% on a Sharpe of 1.5 from its 2 trades. The probabilistic Sharpe (PSR 0.923) looks healthy, but the deflated Sharpe (DSR 0.551), which penalises for 6 trials, is marginal at best.
Strengths and risks
Strengths: the drawdown is negligible, fees are trivial, and the strategy is disciplined — it stays in cash rather than forcing trades.
Risks: the sample is dangerously thin. An entire backtest built on two trades in one fold is a single data point dressed as a track record; the 0% win rate is more noise than signal at this volume. The recent rejected orders and multi-day inactivity suggest the signal rarely clears its own bar, or an execution issue is blocking it.
Verdict: a clean, legible idea that has not yet earned conviction. Keep it on a short leash and small allocation until it accumulates trades across multiple regimes — the concept is sound, but the evidence isn't there yet.